Autoimmune hemolytic anemia in chronic lymphocytic leukemia

Abstract

Chronic lymphocytic leukemia (CLL) is a malignant proliferation of mature, differentiated B-lymphocytes, frequently associated with autoimmune hemolytic anemia (AIHA). The effect of this complication in the clinical outcome and survival of patients with CLL is controversial. The aim of study was to evaluate the prevalence of AIHA in our patients with CLL and how this complication influences the patient's survival.